Inflammatory Arthropathies: Proceedings of a European Symposium, Monte Carlo, 1-4 October 1975E. C. Huskisson, Giampaolo P. Velo |
From inside the book
18 pages matching indomethacin at night in this book
Page 249
Where's the rest of this book?
Results 1-3 of 18
Contents
Experimental acute inflammation P A DIEPPE | 15 |
Cellular pharmacokinetics in inflammation C J DUNN J P GIROUD | 23 |
Inhibition of prostaglandin biosynthesis as the mechanism of action | 31 |
Copyright | |
18 other sections not shown
Common terms and phrases
acid action activity acute adjuvant Ambanelli ankylosing spondylitis anti anti-inflammatory agents anti-inflammatory drugs antibody antigen antipyretic arachidonic Arthus articular aspirin aspirin-like drugs Biol blood bradykinin carrageenan cartilage cells cellular chronic clin clinical complement system components corticosteroids cortisone criteria crystals disease dosage dose enzymes evaluation Experimental arthritis exudate factor Ferreira fever formation GIROUD glandin hemolysis hemolytic histamine human Huskisson immunological increased vascular permeability indomethacin indomethacin at night induced inflammation inflammatory response inhibition injection joint kinin lesions leukocytes lumbago lymphocytes lysosomal mechanism mediators morning stiffness non-steroidal anti-inflammatory non-steroidal anti-inflammatory drugs oedema osteoarthritis pain pathway patients penicillamine PGE2 Pharmacol pharmacological phase phenylbutazone placebo plasma platelet platelet aggregation pleural possible produced properdin prosta pyrogen rabbits rats reaction reduced release Rheum rheumatic rheumatoid arthritis Rheumatology role serotonin serum complement side effects spondylitis substances Table temperature therapeutic therapy tion tissue treatment trial urate Vane Velo Willoughby zymosan µg/ml